299
Last Update Posted: 2016-01-29
Recruiting has ended
All Genders accepted | 21 Years-50 Years |
12 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
The purpose of this study is to develop a clinical protocol to detoxify patients from opiates to naltrexone using buprenorphine and to develop pilot data for a grant application for a controlled study of the efficacy of the new clinical protocol for outpatients.
Eligibility
Relevant conditions:
Opioid-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov